These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 12759548
41. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases. Allard MA, Malka D. J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278 [Abstract] [Full Text] [Related]
42. Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases. White RR, Schwartz LH, Munoz JA, Raggio G, Jarnagin WR, Fong Y, D'Angelica MI, Kemeny NE. J Surg Oncol; 2008 Jun 01; 97(7):601-4. PubMed ID: 18449915 [Abstract] [Full Text] [Related]
45. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Martin RC, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM. Cancer; 2015 Oct 15; 121(20):3649-58. PubMed ID: 26149602 [Abstract] [Full Text] [Related]
46. Idiosyncratic reaction after oxaliplatin: circumvention by use of a continuous infusional administration schedule. Schüll B, Kornek GV, Scheithauer W. Ann Oncol; 2001 Nov 15; 12(11):1653-4. PubMed ID: 11822769 [No Abstract] [Full Text] [Related]
47. Intra-arterial therapies for colorectal cancer liver metastases (radioembolization excluded). de Baere T, Tselikas L, Boige V, Ducreux M, Malka D, Goéré D, Benahim E, Deschamps F. Bull Cancer; 2017 May 15; 104(5):402-406. PubMed ID: 27993355 [Abstract] [Full Text] [Related]
48. Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases. Neyns B, Aerts M, Van Nieuwenhove Y, Fontaine C, De Coster L, Schallier D, Vanderauwera J, De Munck F, Vandenbroucke F, Everaert H, Meert V, De Mey J, De Ridder M, Delvaux G, De Grève J. Anticancer Res; 2008 May 15; 28(4C):2459-67. PubMed ID: 18751435 [Abstract] [Full Text] [Related]
53. Hepatic arterial infusion of irinotecan, 5-Fluorouracil and leucovorin in patients with liver metastases from colorectal carcinoma. Melichar B, Voboril Z, Krajina A, Malírová E, Weiner P, Nová M, Ryska A, Dvorák J. Anticancer Res; 2012 Dec 15; 32(12):5487-93. PubMed ID: 23225456 [Abstract] [Full Text] [Related]
54. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer. Malik Z, Eng C. Clin Adv Hematol Oncol; 2007 Jan 15; 5(1 Suppl 1):4-7. PubMed ID: 17491584 [No Abstract] [Full Text] [Related]
55. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M, Müller HH. J Clin Oncol; 2000 Jan 15; 18(2):243-54. PubMed ID: 10637236 [Abstract] [Full Text] [Related]
56. Treatment of colorectal liver metastases: a review. Van den Eynde M, Hendlisz A. Rev Recent Clin Trials; 2009 Jan 15; 4(1):56-62. PubMed ID: 19149763 [Abstract] [Full Text] [Related]
57. Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives. Chapelle N, Matysiak-Budnik T, Douane F, Metairie S, Rougier P, Touchefeu Y. Dig Liver Dis; 2018 Mar 15; 50(3):220-225. PubMed ID: 29290599 [Abstract] [Full Text] [Related]
58. Induction therapy in patients with metastatic colorectal cancer. Venook AP. Semin Oncol; 2003 Aug 15; 30(4 Suppl 12):25-9. PubMed ID: 14508724 [No Abstract] [Full Text] [Related]